Aquinnova Pharmaceuticals Private Limited

Aquinnova Pharmaceuticals Private Limited - pharma in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
CIN U24290MP2018PTC045407 Incorporated 27 March 2018 ROC Gwalior HQ Indore, Madhya Pradesh, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹5.98 Cr
▲ 7% YoY
Net profit · FY 2025
₹14.08 Lakh
Net margin 2.4%
EBITDA · FY 2025
₹40.91 Lakh
EBITDA margin 6.8%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹17.76 Lakh
Secured borrowings
Company age
8 yrs
Est. 2018
Employees · EPFO
26
Provident fund records

About Aquinnova Pharmaceuticals Private Limited

Data last updated:

Aquinnova Pharmaceuticals Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 March 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24290MP2018PTC045407. Its GSTIN is 23AAQCA7069N1Z0 (Madhya Pradesh).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Jyoti Pathak and Kuldeep Gupta.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Indore, Madhya Pradesh.

As per the financials filed for FY 2025, the company reported a revenue of ₹5.98 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹14.08 Lakh (net margin 2.4%) and EBITDA of ₹40.91 Lakh (EBITDA margin 6.8%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 31% over five years.

The company has about 26 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹17.76 Lakh on record.

Aquinnova Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0033915).

Company details

CIN U24290MP2018PTC045407
Registration Number 045407
Incorporation Date 27 March 2018
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MP-23-0033915

Recognitions & Rankings of Aquinnova Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-MP-23-0033915

Contact details

Aquinnova Pharmaceuticals Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    S.No.116 President Tower, 6/2 South Tukoganj, Indore, Madhya Pradesh, India – 452001
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Aquinnova Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Aquinnova Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Aquinnova Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Aquinnova Pharmaceuticals Private Limited, buy the company report.

Financials of Aquinnova Pharmaceuticals Private Limited

FY 2025 filings available

Aquinnova Pharmaceuticals Private Limited reported revenue of ₹5.98 Cr (up 7% YoY) for FY 2025.

Revenue · FY 2025
₹5.98 Cr ▲ 7%
Net profit · FY 2025
₹14.08 Lakh margin 2.4%
EBITDA · FY 2025
₹40.91 Lakh margin 6.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 11%
5 years · compounded
▲ 31%
EBITDA CAGR growth
1 year
▲ 85%
3 years · compounded
▲ 24%
5 years · compounded
▲ 45%

Revenue has grown at a compounded annual rate (CAGR) of 31% over five years, including 7% growth in the latest year. EBITDA rose 85% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹40.91 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹14.08 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin6.8%
Net Profit Margin2.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Aquinnova Pharmaceuticals Private Limited, buy the company report.

Board of directors of Aquinnova Pharmaceuticals Private Limited

Aquinnova Pharmaceuticals has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Jyoti PathakDirector27 Mar 20188 Years 7 MonthsCurrent
Kuldeep GuptaDirector27 Mar 20188 Years 7 MonthsCurrent
Mahendra NokhwalDirector27 Mar 20188 Years 7 MonthsCurrent

Peer comparison

Aquinnova Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Nyx Pharmaceuticals Private Limited₹6.02 Cr (FY 2024)32.0%Chandigarh, India
Corona Pharmaceuticals Private Limited.₹6.01 Cr (FY 2025)5.0%Kashipur, Uttarakhand, India
Aquinnova Pharmaceuticals Private Limitedthis company₹5.98 Cr (FY 2025)₹14.08 Lakh2.4%7.0%26Indore, Madhya Pradesh, India
Donas Drugs and Pharmaceuticals Private Limited₹5.93 Cr (FY 2020)-11.0%Chennai, Tamil Nadu, India
Doleshwor Pharmaceuticals Private Limited₹5.93 Cr (FY 2025)-36.0%New Delhi, Delhi, India

To see the full peer comparison of Aquinnova Pharmaceuticals Private Limited, buy the company report.

Auditor

Aquinnova Pharmaceuticals Private Limited is audited by DASSANI & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
DASSANI & ASSOCIATESFY 2023009096C

Shareholding

The shareholding of Aquinnova Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Aquinnova Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹17.76 Lakh
Satisfied charges
None
Breakdown by lending institutions
Others₹0.18 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
14 Aug 2020100376134Others₹6.1 LakhOpen
27 Jan 2020100376138Others₹5.5 LakhOpen
16 Jan 2020100375949Others₹6.16 LakhOpen

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Aquinnova Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Aquinnova Pharmaceuticals Private Limited has a workforce of 26 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.

Employee count
26
Active EPFO establishments
1
Employee growth
8.33%

GST

Aquinnova Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
23AAQCA7069N1Z0Madhya PradeshActive25 Jul 2018

To see the full GST registrations and return filing status of Aquinnova Pharmaceuticals Private Limited, buy the company report.

Recent activity

Aquinnova Pharmaceuticals Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Jyoti Pathak was appointed as Director on 27 Mar 2018.

AGM
Aquinnova Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Aquinnova Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Charges
A charge with Others amounted to Rs. 6.10 Lakh with Charge ID 100376134 was registered on 14 Aug 2020.
Charges
A charge with Others amounted to Rs. 5.50 Lakh with Charge ID 100376138 was registered on 27 Jan 2020.
Charges
A charge with Others amounted to Rs. 6.16 Lakh with Charge ID 100375949 was registered on 16 Jan 2020.
Appointed
Jyoti Pathak was appointed as Director.
Appointed
Kuldeep Gupta was appointed as Director.
Appointed
Mahendra Nokhwal was appointed as Director.
Incorporation
27 Mar 2018
Aquinnova Pharmaceuticals Private Limited was registered on 27 Mar 2018 with Roc Gwalior & aged 8 years 7 months as per MCA records.

Frequently asked questions

Aquinnova Pharmaceuticals is an active private limited company based in Indore, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 March 2018 (8+ years old) and is registered under CIN U24290MP2018PTC045407.

Aquinnova Pharmaceuticals has 3 current directors:

The latest financial statements of Aquinnova Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.

The GSTIN of Aquinnova Pharmaceuticals is 23AAQCA7069N1Z0, registered in Madhya Pradesh.

The CIN (Corporate Identification Number) of Aquinnova Pharmaceuticals is U24290MP2018PTC045407. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Aquinnova Pharmaceuticals was incorporated on 27 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Gwalior.

The peers of Aquinnova Pharmaceuticals by revenue are Nyx Pharmaceuticals Private Limited, Corona Pharmaceuticals Private Limited, Donas Drugs and Pharmaceuticals Private Limited, Doleshwor Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).

Jyoti Pathak was appointed as Director on 27 Mar 2018. Kuldeep Gupta was appointed as Director on 27 Mar 2018. Mahendra Nokhwal was appointed as Director on 27 Mar 2018.

Yes, Aquinnova Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-23-0033915).

The registered office of Aquinnova Pharmaceuticals is at S.No.116 President Tower, 62 South Tukoganj, Indore, Madhya Pradesh, India – 452001.

Aquinnova Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.